Median PFS showed a positive trend in the DEX group when compared to the non-DEX group (5.20 months vs 2.87 months), but was not significant ( P = 0.0640).
← all excerpts
A Retrospective Analysis of the Efficacy of Oral Dexamethasone in Combination With Docetaxel Plus Ramucirumab Therapy for Previously Treated Lung Cancer.
1
—
—